India, Oct. 7 -- China SXT Pharmaceuticals, Inc. (SXTC)
China SXT Pharmaceuticals develops and commercializes traditional Chinese medicine products.The company saw shares surge more than 536% on Wednesday, without any specific company-related news identified as the immediate catalyst.The move follows a 1-for-80 share consolidation effective August 10, 2026, which sharply reduced the public share count. In July, SXTC announced a $9 million registered direct offering and financing of up to $31.5 million. In August, it amended the financing, lowering the share price floor to $0.20.
Currently, SXTC is trading at $6.60, up 456.59%.
VERAXA Biotech (VRXA)
VERAXA Biotech develops next-generation antibody-based cancer therapies, including BiTAC ...